Key facts
- Notable investors include Startup TNT.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Oncoforma Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Oncoforma Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oncoforma Biotechnologies
Provider of precision oncology testing services designed to guide cancer treatment decisions using patient-derived tumor organoids. The company combines functional drug testing with genomic analysis by culturing 3D tumor organoids and screening them against a comprehensive panel of therapies, enabling cancer patients to access personalized treatment plans and effective therapies for those who have exhausted standard treatments.
- Sector
- Healthcare
- HQ
- Saskatoon, Canada
- Founded
- 2025
- Employees
- 2
- Website
- oncoforma.com/
- Ownership
- Privately Held (backing)
Oncoforma Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oncoforma Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oncoforma Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.